How to Buy Xeris Biopharma Holdings Stock
Xeris Biopharma Holdings Inc
Xeris Biopharma Holdings, Inc. operates as a biopharmaceutical company, focusing on the development and commercialization of therapeutic solutions for individuals across the fields of endocrinology, neurology, and gastroenterology.
Xeris Biopharma Holdings stock last closed at $6.90, up 0.29% from the previous day, and has increased 56.82% in one year. It has overperformed other stocks in the Biotechnology industry by 1.29 percentage points. Xeris Biopharma Holdings stock is currently +56.78% from its 52-week low of $4.40, and -31.55% from its 52-week high of $10.08.
There are currently 172.64M XERS shares outstanding. The market cap of XERS is $1.19B. In the past 24 hours, 1.42M XERS shares were traded.
How to Buy Xeris Biopharma Holdings Stock
Wondering how to invest in Xeris Biopharma Holdings stock? Here's how.
- Choose where to buy Xeris Biopharma Holdings stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Xeris Biopharma Holdings stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Choose your payment method and add your info.
- Research Xeris Biopharma Holdings stock: The Xeris Biopharma Holdings ticker symbol is XERS. Is Xeris Biopharma Holdings stock a good investment? Should you buy shares of XERS? How do XERS's underlying business fundamentals look? Do top analysts think Xeris Biopharma Holdings is a good buy? Why has XERS's stock price moved recently? (Hint: Our stock research tools can help you understand if XERS is a good stock to buy).
- Place your XERS trade: Decide if you will purchase XERS shares at the current market price or use a limit order to purchase XERS stock at a given price.
- Get notifications regarding your XERS investment: Create a watchlist to watch your investment in Xeris Biopharma Holdings stock.
Step 1: Choose where to buy Xeris Biopharma Holdings stock
You need a brokerage account to access the NASDAQ market and buy XERS stock.
Our preferred brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen your brokerage, it's time to fill out some personal info so you are able to invest in XERS today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start a new brokerage account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've finished signing up on the best stock app, you need to deposit funds:
Watch this video walkthrough for more details transferring money into your new investment account.
Step 4: Research Xeris Biopharma Holdings stock
Once you have decided on the best place to buy Xeris Biopharma Holdings stock, it's crucial to evaluate their stock before you buy, so you can understand the risk and upside.
Xeris Biopharma Holdings stock quick numbers
XERS Fundamentals
WallStreetZen was created to help everyday investors do more accurate fundamental analysis quickly.
You can see all of the due diligence checks on XERS's stock page.
Is XERS stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge XERS's true value.
Using relative valuations ratios:
- XERS could be overvalued based on its P/E ratio of 98.57x, relative to Biotechnology industry P/E ratio of 16.03x
- XERS may be overvalued based on its P/B ratio of 91.56x, relative to Biotechnology industry P/B ratio of 4.86x
- XERS could be undervalued based on its PEG ratio of 0.91x
You can access additional valuation analysis on XERS's stock here.
XERS Financial Summary
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the XERS balance sheet.
- XERS profit margin has gone up from -20.3% to 3.8% in the past year.
Negative Financial Indicators:
- Total XERS debt is higher than 5 years ago, relative to shareholder equity.
- XERS has a relatively high debt to equity ratio of 29.13.
- There are more long-term liabilities than short-term assets on the XERS balance sheet.
- XERS earnings of $40.67M is not enough to cover its interest payments.
- XERS's operating cash flow of $48.53M allows it to safely service it's debt of $258.55M.
Is XERS stock a Buy, Hold, or Sell, according to analysts?
Out of 1 sell side analysts who track XERS, the consensus analyst rating on Xeris Biopharma Holdings is a Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Xeris Biopharma Holdings stock forecast page.
XERS Technical Indicators
XERS Growth Metrics
Last year, XERS revenue was $314.85M. In the last 5 year, XERS's revenue has grown by 63.63% per year. This was faster than the Biotechnology industry average of 32.16%.
You can research XERS's earnings and revenue performance here.
Are XERS insiders buying or selling the stock?
Over the past 12 months, executives and large shareholders at XERS have sold more shares than they have bought.
Barbarajean Anne Bormannkennedy, Director of XERS, was the latest XERS insider to sell. They sold $97,504.00 worth of XERS stock on Jun 4, 2026.
Research more about who owns XERS shares here.
Can I rely on XERS as an income stream?
No, Xeris Biopharma Holdings doesn't provide an income stream by paying out dividends.
What others are saying about XERS
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your XERS trade
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount, use a limit order.
Press the Open Trade button and eToro will place your order.
If you need additional info about investing in stocks on eToro, click the helpful video below:
Step 6: Get notifications regarding your XERS investment
Now that you own some XERS stock, you'll want to keep up with your new investment.
Start a watchlist to see the latest developments about your XERS stock.
XERS Feed
How to Buy Stock in Xeris Biopharma Holdings
To reiterate, here are the 6 steps you need to take to buy Xeris Biopharma Holdings stock right now:
- Choose where to buy Xeris Biopharma Holdings stock
- Create a brokerage account
- Deposit funds into your investment account
- Research Xeris Biopharma Holdings stock
- Place your XERS trade
- Get notifications regarding your XERS investment
If you need a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to monitor your new investment in Xeris Biopharma Holdings, click the button below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.